TELA - TELA Bio

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• TELA Bio GAAP EPS of -$0.63 misses by $0.04, revenue of $11.9M in-line
• TELA prices $45M public offering
• TELA Bio commences equity offering
• TELA Bio wins FDA nod for soft tissue reconstruction product
• TELA Bio GAAP EPS of -$0.52 beats by $0.03, revenue of $11.6M misses by $1.59M
• TELA Bio bags biosynthetic mesh products agreement
• TELA Bio GAAP EPS of -$0.64 misses by $0.02, revenue of $11.2M beats by $0.33M
• TELA Bio closes $36.8M underwritten public offering
• Tela Bio prices $32M common stock offering
• TELA Bio slides aftermarket on stock offering
• TELA Bio Q2 GAAP EPS of -$0.88, revenue of $10.4M, FY22 guidance in-line with consensus
• TELA Bio secures up to $50M debt financing from MidCap Financial
• TELA Bio GAAP EPS of -$0.75 misses by $0.14, revenue of $8.23M beats by $0.28M
• TELA Bio GAAP EPS of -$0.59 misses by $0.07, revenue of $8.37M beats by $0.4M
• TELA Bio launches SiteGuard for use in plastic reconstructive surgery
• TELA Bio beats on revenue
• TELA Bio inks exclusive distribution agreement with Next Science
• TELA Bio names new COO & CFO
• TELA Bio beats on revenue
• TELA Bio initiates post-market study of Ovitex for the robotic repair of ventral hernias